It's that time again! Jim Cramer rang the lightning round bell, which means he gave his take on caller favorite stocks at rapid speed:

Juno Therapeutics: "It's a speculative biotech in a world where even the stable biotechs are going down. So, you have to understand that stock is probably going lower in this kind of market until year end. So, act accordingly."

Calumet Specialty Products Partners: "I think that yield is unsustainable. I think you should take some off the table. I really do. I know that hurts to hear, but I think you should take some off the table."

First Data Corp: "Listen, we've got a company like a Mastercard. We don't need First Data Corp. We've got Mastercard, and that's what we're going to do."

AT&T: "I'm with you, I know most aren't. The stock's been a total dog, but they boosted the dividend and that's fine with me. It's 'steady Eddie' it's not going up, not going down — but you're getting the yield. Eventually I think DirectTV is going to work and it will go higher."

Read more from Mad Money with Jim Cramer

Cramer Remix: Selling this stock is totally unfair
Cramer: Be skeptical of any upward market moves
Cramer: Apple has taken a beating. Still worth it?

Shopify Inc: "I just saw a merchant that used Shopify when I was shopping in Brooklyn on Atlantic Avenue. I think this thing is very good. I was going through the mechanisms of it, and I like that stock. It's really down a lot."

Alcoa Inc: "Alcoa will not really start going higher until we get closer to the break up of the company, because people do not want to own a company levered to any minerals or mining."

Questions for Cramer?
Call Cramer: 1-800-743-CNBC

Want to take a deep dive into Cramer's world? Hit him up!
Mad Money Twitter - Jim Cramer Twitter - Facebook - Instagram - Vine

Questions, comments, suggestions for the "Mad Money" website? madcap@cnbc.com